In this study, we observed that in COVID-19 patients, severe eosinopenia was associated with elevated circulating concentrations of IP-10, an inflammatory chemokine whose levels have been strongly associated with ARDS occurrence [20]. This evidence concerns the gene CXCL10 and acute respiratory distress syndrome.